TCG Crossover Management »

First Tracks Biotherapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $58M 2.9M 20.12

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Bank of America Corporation
Sofinnova Ventures

View all funds holding First Tracks Biotherapeutics